Drug Pipeline

Topotecan Hydrochloride for Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07418749 A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With… Recurrent Cervical Cancer Recruiting
NCT06828354 A Study of SHR-A1811 in Subjects With Ovarian Cancer Ovarian Cancer Recruiting
NCT06612151 A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer Small Cell Lung Cancer Active, Not Recruiting
Sponsors Running Topotecan Hydrochloride for Injection Trials
MediLink Therapeutics (Suzhou) Co., Ltd. (1) Jiangsu HengRui Medicine Co., Ltd. (1) Suzhou Suncadia Biopharmaceuticals Co., Ltd. (1)
Disease Areas
Small Cell Lung Cancer (1) Lung Cancer (1) Ovarian Cancer (1) Cervical Cancer (1)
Get alerts when Topotecan Hydrochloride for Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free